Related Experiment Video
Updated: Oct 1, 2025

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
Uremic toxins activate CREB/ATF1 in endothelial cells related to chronic kidney disease
Regiane Stafim da Cunha1, Paulo Cézar Gregório1, Rayana Ariane Pereira Maciel1
1Experimental Nephrology Laboratory, Basic Pathology Department, Universidade Federal do Paraná, Curitiba, PR, Brazil.
Abstract:
Uremic toxins, such as p-cresyl sulfate (PCS) and indoxyl sulfate (IS), contribute to endothelial dysfunction in chronic kidney disease (CKD). This process is mediated by several cellular pathways, but it is unclear whether cAMP-responsive element-binding protein (CREB) and activating transcription factor 1 (ATF1) participate in endothelial dysfunction in uremic conditions despite playing roles in inflammatory modulation. This study aimed to evaluate the expression, activation, and transcriptional activity of CREB/ATF1 in endothelial cells exposed to PCS, IS, and uremic serum (US). In vitro, ATF1 protein levels were increased by PCS and IS, whereas CREB levels were enhanced only by IS. Activation through CREB-Ser133 and ATF1-Ser63 phosphorylation was induced by PCS, IS, and US. We evaluated the CREB/ATF1 transcriptional activity by analyzing the expression of their target genes, including ICAM1, PTGS2, NOX1, and SLC22A6, which are related to endothelial dysfunction through their roles in vascular inflammation, oxidative stress, and cellular uptake of PCS and IS. The expression of ICAM1, PTGS2 and NOX1 genes was increased by PCS, IS, and US, whereas that of SLC22A6 was induced only by IS. KG-501, a CREB inhibitor, restored the inductive effects of PCS on ICAM1, PTGS2, and NOX1 expression; IS on ICAM1, PTGS2 and SLC22A6 expression; and US on NOX1 expression. The presence of CREB and ATF1 was observed in healthy arteries and in arteries of patients with CKD, which were structurally damaged. These findings suggest that CREB/ATF1 is activated by uremic toxins and may play a relevant role in endothelial dysfunction in CKD.
Insights
Uremic toxins like p-cresyl sulfate and indoxyl sulfate activate cAMP-responsive element-binding protein (CREB) and activating transcription factor 1 (ATF1) in endothelial cells. This activation contributes to endothelial dysfunction in chronic kidney disease (CKD).
Area of Science:
- Nephrology
- Molecular Biology
- Cardiovascular Research
Background:
- Uremic toxins, including p-cresyl sulfate (PCS) and indoxyl sulfate (IS), are implicated in endothelial dysfunction in chronic kidney disease (CKD).
- The roles of cAMP-responsive element-binding protein (CREB) and activating transcription factor 1 (ATF1) in uremic endothelial dysfunction are not fully understood, despite their involvement in inflammatory pathways.
Purpose of the Study:
- To investigate the expression, activation, and transcriptional activity of CREB and ATF1 in endothelial cells exposed to uremic toxins.
- To determine the potential involvement of CREB/ATF1 in the endothelial dysfunction associated with CKD.
Main Methods:
- In vitro exposure of endothelial cells to PCS, IS, and uremic serum (US).
- Assessment of CREB and ATF1 protein levels, phosphorylation (activation), and transcriptional activity of target genes (ICAM1, PTGS2, NOX1, SLC22A6).
- Inhibition of CREB using KG-501 to evaluate its role in toxin-induced gene expression.
Main Results:
- PCS and IS increased ATF1 protein levels; IS also increased CREB levels.
- PCS, IS, and US induced CREB-Ser133 and ATF1-Ser63 phosphorylation.
- Uremic toxins upregulated inflammatory and oxidative stress genes (ICAM1, PTGS2, NOX1), with IS also affecting SLC22A6.
- CREB inhibition partially reversed the effects of uremic toxins on target gene expression.
Conclusions:
- CREB and ATF1 are activated by uremic toxins (PCS, IS, US) in endothelial cells.
- Activated CREB/ATF1 signaling contributes to endothelial dysfunction in CKD by modulating inflammatory and oxidative stress pathways.
- CREB/ATF1 represents a potential therapeutic target for mitigating endothelial dysfunction in CKD.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease I: Introduction
Regulation of Angiogenesis and Blood Supply
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction

